This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Man collecting prescription from pharmacist

    GLP-1 receptor agonists: kidney and cardiovascular outcomes in people with CKD

  • Human circulatory system

    Arterial stiffness and incidence of chronic kidney disease

  • Scientist in laboratory

    Alternative complement pathway inhibition with iptacopan in IgA nephropathy

  • Pills being tipped into a hand

    Iptacopan in IgA nephropathy

  • Patient in a consultation

    PARAGON-HF: Kidney function and cardiovascular outcomes with sacubitril/valsartan

  • Heart concept image

    BARACK-D: low-dose spironolactone and cardiovascular outcomes in moderate CKD

  • Rack of blood sample tubes

    Do we fully understand the risk factors associated with venous thromboembolism in nephrotic syndrome?

  • Risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels

  • Effects of heart failure therapies on standardised kidney outcomes

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe